Loading...
Rising Pricing Pressures And Biosimilar Challenges Will Weaken Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
30.9%7D
-1.7%1Y
30.9%7D
-1.7%You can edit this narrative until Aug 24 10:57 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 24 10:57 PM. Then, changes will post as Updates.